Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study.
Angiotensin-Converting Enzyme 2
/ chemistry
Biflavonoids
/ chemistry
Binding Sites
/ physiology
COVID-19
/ metabolism
Catechin
/ analogs & derivatives
Computational Biology
/ methods
Gallic Acid
/ analogs & derivatives
Humans
Hydroxychloroquine
/ chemistry
Molecular Docking Simulation
/ methods
Protein Structure, Secondary
Protein Structure, Tertiary
Spike Glycoprotein, Coronavirus
/ chemistry
X-Ray Diffraction
/ methods
ACE2
PatchDock
SARS-CoV-2 or COVID-19
hydroxychloroquine
pandemic global outbreak
spike glycoprotein
tea flavonoids
Journal
Drug development research
ISSN: 1098-2299
Titre abrégé: Drug Dev Res
Pays: United States
ID NLM: 8204468
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
22
04
2020
revised:
11
07
2020
accepted:
14
07
2020
pubmed:
10
8
2020
medline:
20
2
2021
entrez:
10
8
2020
Statut:
ppublish
Résumé
SARS-CoV-2 or COVID-19 pandemic global outbreak created the most unstable situation of human health-economy. In the past two decades different parts of the word experienced smaller or bigger outbreak related to human coronaviruses. The spike glycoproteins of the COVID-19 (similar to SARS-CoV) attach to the angiotensin-converting enzyme (ACE2) and transit over a stabilized open state for the viral internalization to the host cells and propagate with great efficacy. Higher rate of mutability makes this virus unpredictable/less sensitive to the protein/nucleic acid based drugs. In this emergent situation, drug-induced destabilization of spike binding to RBD could be a good strategy. In the current study we demonstrated by bioinformatics (CASTp: computed atlas of surface topography of protein, PyMol: molecular visualization) and molecular docking (PatchDock and Autodock) experiments that tea flavonoids catechin products mainly epigallocatechin gallate or other like theaflavin gallate demonstrated higher atomic contact energy (ACE) value, binding energy, Ki value, ligand efficiency, surface area and more amino acid interactions than hydroxychloroquine (HCQ) during binding in the central channel of the spike protein. Moreover, out of three distinct binding sites (I, II and III) of spike core when HCQ binds only with site III (farthest from the nCoV-RBD of ACE2 contact), epigallocatechin gallate and theaflavin gallate bind all three sites. As sites I and II are in closer contact with open state location and viral-host contact area, these drugs might have significant effects. Taking into account the toxicity/side effects by chloroquine/HCQ, present drugs may be important. Our laboratory is working on tea flavonoids and other phytochemicals in the protection from toxicity, DNA/mitochondrial damage, inflammation and so on. The present data might be helpful for further analysis of flavonoids in this emergent pandemic situation.
Identifiants
pubmed: 32770567
doi: 10.1002/ddr.21730
pmc: PMC7436314
doi:
Substances chimiques
Biflavonoids
0
Spike Glycoprotein, Coronavirus
0
spike protein, SARS-CoV-2
0
theaflavine gallate
31629-79-5
Hydroxychloroquine
4QWG6N8QKH
Gallic Acid
632XD903SP
Catechin
8R1V1STN48
epigallocatechin gallate
BQM438CTEL
ACE2 protein, human
EC 3.4.17.23
Angiotensin-Converting Enzyme 2
EC 3.4.17.23
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
86-96Subventions
Organisme : Partially by WB State DST
ID : 05/2016
Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Am J Ther. 2007 Sep-Oct;14(5):455-61
pubmed: 17890935
Viruses. 2020 Feb 04;12(2):
pubmed: 32033244
J Virol. 2014 Jul;88(14):7806-17
pubmed: 24789779
Antiviral Res. 2014 Nov;111:100-11
pubmed: 25260897
Arch Acad Emerg Med. 2020 Mar 9;8(1):e17
pubmed: 32185369
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2014;32(4):338-61
pubmed: 25436473
Ann Intern Med. 2020 Jun 2;172(11):754-755
pubmed: 32232419
Am J Ther. 2007 Sep-Oct;14(5):462-8
pubmed: 17890936
Life Sci. 2020 Jul 15;253:117592
pubmed: 32222463
Antivir Chem Chemother. 2011 Jul 04;21(6):239-43
pubmed: 21730371
Biochemistry. 1990 Mar 20;29(11):2841-5
pubmed: 1693287
Molecules. 2018 Sep 27;23(10):
pubmed: 30262731
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Viruses. 2014 Feb 21;6(2):938-50
pubmed: 24566281
Molecules. 2018 Jul 20;23(7):
pubmed: 30037024
Hepatology. 2011 Dec;54(6):1947-55
pubmed: 21837753
Environ Toxicol. 2015 Sep;30(9):1033-44
pubmed: 24615952
Cent Nerv Syst Agents Med Chem. 2017;17(3):187-195
pubmed: 28155600
Antiviral Res. 2015 Jan;113:1-3
pubmed: 25446334
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Brain Res. 2006 Dec 6;1123(1):216-225
pubmed: 17078933
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
J Chin Med Assoc. 2018 May;81(5):458-468
pubmed: 29287704
Virology. 2005 May 10;335(2):276-85
pubmed: 15840526
Chem Commun (Camb). 2012 Feb 28;48(18):2421-3
pubmed: 22266839
Nature. 2020 Mar;579(7799):321
pubmed: 32179860
Nucleic Acids Res. 2018 Jul 2;46(W1):W363-W367
pubmed: 29860391
Int J Antimicrob Agents. 2020 Apr;55(4):105944
pubmed: 32179150
Int J Antimicrob Agents. 2020 Apr;55(4):105932
pubmed: 32145363
J Altern Complement Med. 2006 Sep;12(7):669-72
pubmed: 16970537
Hepatology. 2012 Mar;55(3):720-9
pubmed: 22105803
Drug Dev Res. 2021 Feb;82(1):86-96
pubmed: 32770567
J Crit Care. 2020 Jun;57:279-283
pubmed: 32173110
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W363-7
pubmed: 15980490